151 related articles for article (PubMed ID: 35181263)
1. Machine learning to distinguish lymphangioleiomyomatosis from other diffuse cystic lung diseases.
Jonas A; Muelly M; Gupta N; Reicher JJ
Respir Investig; 2022 May; 60(3):430-433. PubMed ID: 35181263
[TBL] [Abstract][Full Text] [Related]
2. Diffuse cystic lung diseases: correlation between radiologic and functional status.
Paciocco G; Uslenghi E; Bianchi A; Mazzarella G; Roviaro GC; Vecchi G; Harari S
Chest; 2004 Jan; 125(1):135-42. PubMed ID: 14718432
[TBL] [Abstract][Full Text] [Related]
3. Chest Computed Tomographic Image Screening for Cystic Lung Diseases in Patients with Spontaneous Pneumothorax Is Cost Effective.
Gupta N; Langenderfer D; McCormack FX; Schauer DP; Eckman MH
Ann Am Thorac Soc; 2017 Jan; 14(1):17-25. PubMed ID: 27737563
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary lymphangioleiomyomatosis--review and personal results].
Kirchner J; Lörcher U
Rontgenpraxis; 2001; 53(6):250-5. PubMed ID: 11402873
[TBL] [Abstract][Full Text] [Related]
5. Cystic lung disease lymphangioleiomyomatosis (LAM) in a male patient.
Prakash AK; Chatterjee S; Datta B; Jaiswal A
BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37076194
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary lymphangioleiomyomatosis: analysis of disease manifestation by region-based quantification of lung parenchyma.
Theilig D; Doellinger F; Kuhnigk JM; Temmesfeld-Wollbrueck B; Huebner RH; Schreiter N; Poellinger A
Eur J Radiol; 2015 Apr; 84(4):732-7. PubMed ID: 25604910
[TBL] [Abstract][Full Text] [Related]
7. Difference of the progression of pulmonary cysts assessed by computed tomography among COPD, lymphangioleiomyomatosis, and Birt-Hogg-Dubé syndrome.
Tobino K; Hirai T; Johkoh T; Fujimoto K; Kawaguchi A; Tomiyama N; Takahashi K; Seyama K
PLoS One; 2017; 12(12):e0188771. PubMed ID: 29220357
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary lymphangioleiomyomatosis in a male patient with tuberous sclerosis complex.
Miyake M; Tateishi U; Maeda T; Kusumoto M; Satake M; Arai Y; Sugimura K
Radiat Med; 2005 Nov; 23(7):525-7. PubMed ID: 16485546
[TBL] [Abstract][Full Text] [Related]
9. Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis.
Ussavarungsi K; Hu X; Scott JP; Erasmus DB; Mallea JM; Alvarez F; Lee AS; Keller CA; Ryu JH; Burger CD
Respir Med; 2015 Oct; 109(10):1354-9. PubMed ID: 26321137
[TBL] [Abstract][Full Text] [Related]
10. Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis.
Crausman RS; Lynch DA; Mortenson RL; King TE; Irvin CG; Hale VA; Newell JD
Chest; 1996 Jan; 109(1):131-7. PubMed ID: 8549175
[TBL] [Abstract][Full Text] [Related]
11. Imaging of cystic lung disease.
Gillott M; Flemming B; Ravenel JG
Semin Roentgenol; 2015 Jan; 50(1):23-30. PubMed ID: 25498400
[No Abstract] [Full Text] [Related]
12. Diffuse Cystic Lung Diseases.
Obaidat B; Yazdani D; Wikenheiser-Brokamp KA; Gupta N
Respir Care; 2020 Jan; 65(1):111-126. PubMed ID: 31615921
[TBL] [Abstract][Full Text] [Related]
13. Screening for lymphangioleiomyomatosis by high-resolution computed tomography in young, nonsmoking women presenting with spontaneous pneumothorax is cost-effective.
Hagaman JT; Schauer DP; McCormack FX; Kinder BW
Am J Respir Crit Care Med; 2010 Jun; 181(12):1376-82. PubMed ID: 20167846
[TBL] [Abstract][Full Text] [Related]
14. Quantitative CT analysis of small pulmonary vessels in lymphangioleiomyomatosis.
Ando K; Tobino K; Kurihara M; Kataoka H; Doi T; Hoshika Y; Takahashi K; Seyama K
Eur J Radiol; 2012 Dec; 81(12):3925-30. PubMed ID: 22964373
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).
Baldi BG; Araujo MS; Freitas CS; da Silva Teles GB; Kairalla RA; Dias OM; Pereira DA; Pimenta SP; Carvalho CR
Lung; 2014 Dec; 192(6):967-74. PubMed ID: 25201087
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic usefulness of transbronchial lung cryobiopsy in two patients mildly affected with pulmonary lymphangioleiomyomatosis.
Yoshida M; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Izumo T
Respir Investig; 2020 Jul; 58(4):295-299. PubMed ID: 32265154
[TBL] [Abstract][Full Text] [Related]
17. From the archives of the AFIP: lymphangioleiomyomatosis: radiologic-pathologic correlation.
Abbott GF; Rosado-de-Christenson ML; Frazier AA; Franks TJ; Pugatch RD; Galvin JR
Radiographics; 2005; 25(3):803-28. PubMed ID: 15888627
[TBL] [Abstract][Full Text] [Related]
18. Role of thoracic imaging in the management of lymphangioleiomyomatosis.
Crivelli P; Ledda RE; Terraneo S; Conti M; Imeri G; Lesma E; Di Marco F
Respir Med; 2019 Oct; 157():14-20. PubMed ID: 31470185
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings.
Kirchner J; Stein A; Viel K; Dietrich CF; Thalhammer A; Schneider M; Jacobi V
Eur Radiol; 1999; 9(1):49-54. PubMed ID: 9933379
[TBL] [Abstract][Full Text] [Related]
20. Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.
Kim C; Do KH; Cha J; Song JW; Lee SM; Lee KY
Eur Radiol; 2020 Feb; 30(2):735-743. PubMed ID: 31471750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
